Ingolf Schult

Ingolf Schult possesses extensive experience in business development and marketing within the medical device and pharmaceutical industries. Currently serving as the Director of Business Development & Clinical Affairs at Hemoteq AG since May 2009, Ingolf also took a sabbatical during this period. Previous roles include Business Director at mnemoscience GmbH, International Product Manager at angiomed (a subsidiary of C.R. Bard, Germany), and Marketing Manager at Hemoteq GmbH. Ingolf's early career involved various positions at Cordis, a Johnson & Johnson Company, where responsibilities included product management and clinical research across multiple European markets. Additional experience includes roles at Sigma-Aldrich and Bristol-Myers Squibb, focusing on sales, scientific support, and clinical trials in the cardiovascular sector.